Cytokinetics (CYTK) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to $7.7 million.
- Cytokinetics' Other Non-Current Assets fell 564.31% to $7.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $7.7 million, marking a year-over-year decrease of 564.31%. This contributed to the annual value of $8.0 million for FY2023, which is 1749.05% down from last year.
- Per Cytokinetics' latest filing, its Other Non-Current Assets stood at $7.7 million for Q3 2024, which was down 564.31% from $7.7 million recorded in Q2 2024.
- Over the past 5 years, Cytokinetics' Other Non-Current Assets peaked at $9.7 million during Q4 2022, and registered a low of $6.4 million during Q4 2020.
- For the 5-year period, Cytokinetics' Other Non-Current Assets averaged around $7.6 million, with its median value being $7.7 million (2022).
- Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 3482.19% in 2022, then crashed by 1749.05% in 2023.
- Cytokinetics' Other Non-Current Assets (Quarter) stood at $6.4 million in 2020, then grew by 13.05% to $7.2 million in 2021, then soared by 34.82% to $9.7 million in 2022, then decreased by 17.49% to $8.0 million in 2023, then decreased by 3.39% to $7.7 million in 2024.
- Its Other Non-Current Assets stands at $7.7 million for Q3 2024, versus $7.7 million for Q2 2024 and $7.8 million for Q1 2024.